Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Interpace Diag Group (IDXG)

Interpace Diag Group (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Interpace Diag Group WATERVIEW PLAZA SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054 USA

www.interpace.com P: 855-776-6419

Description:

Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.

Key Statistics

Overview:

Market Capitalization, $K 4,895
Enterprise Value, $K 52,175
Shares Outstanding, K 4,370
Annual Sales, $ 40,210 K
Annual Net Income, $ 800 K
Last Quarter Sales, $ 10,270 K
Last Quarter Net Income, $ 470 K
EBIT, $ 3,860 K
EBITDA, $ 5,500 K
60-Month Beta 0.67
% of Insider Shareholders 6.50%
% of Institutional Shareholders 5.73%
Float, K 4,086
% Float 93.50%
Short Volume Ratio 0.89

Growth:

1-Year Return -49.09%
3-Year Return -87.20%
5-Year Return -86.98%
5-Year Revenue Growth 83.61%
5-Year Earnings Growth 105.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.13 on 05/09/24
Next Earnings Date 08/14/24
Earnings Per Share ttm 0.10
EPS Growth vs. Prev Year 30.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/15/20

IDXG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2.03%
Return-on-Assets % 9.06%
Profit Margin % 1.99%
Debt/Equity -0.02
Price/Sales 0.13
Price/Cash Flow 1.82
Price/Book N/A
Book Value/Share -13.99
Interest Coverage 11.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar